Implenia

Divisions

Some of our projects

Investor Relations

Media

Current

Archiv

29 May 2008

18 Apr 2008

8 Apr 2008

28 Mar 2008

25 Mar 2008

11 Mar 2008

10 Mar 2008

16 Feb 2008

1 Feb 2008

29.01.2008

25.1.2008

14 Dec 2007

13 Dec 2007

5 Dec 2007

30 Nov 2007

23 Nov 2007

19 Nov 2007

16 Nov 2007

2 Nov 2007

13 Sep 2007

8 Jun 2007

30.5.2007

24.4.2007

18.4.2007

11.4.2007

22 Mar 07

12.9.2006

7.9.2006

22.6.2006

2.3.2006

21.2.2006

30.1.2006

20.12.2005

15.11.2005

Image bank

Contact

Job Opportunities

Contact

Implenia's AGM approves all board proposals

The Annual General Meeting of Implenia AG has approved all the proposals made by the company's Board of Directors.

D i e t l i k o n, 8 April 2008 – Buoyed by the excellent group results posted for 2007, the majority of shareholders present voted to reduce the par value of each Implenia registered share by CHF 0.50 to CHF 4.00 (previous year: par value reduction of CHF 0.35 to CHF 4.50 per registered share). As recommended by the Board of Directors, a clear majority of shareholders rejected the proposals made by Laxey Partners Ltd. to annul the conditional capital and reduce the terms of office of members of the Board of Directors. Urs Häner, CEO of Russian Land, Implenia's Russian joint venture partner, was newly elected to Implenia's Board of Directors. Anton Affentranger, Markus Dennler, Claudio Generali, Patrick Hünerwadel, Toni Wicki and Philippe Zoelly were all re-elected for a further two-year term.

Chairman of the Board of Directors Anton Affentranger confirmed to the assembled shareholders that Laxey had acted illegally when buying its Implenia shares and in so doing had harmed all shareholders and the company as a whole. For this reason, and based on the Federal Banking Commission's investigation into the matter, the Board of Directors will be working hard to ensure that Laxey is brought to account for its illegal actions and for the damage it has done. The Board will not be put off by Laxey's numerous attempts to put pressure on Implenia, especially since shareholders have now so overwhelmingly rejected Laxey's takeover offer. In its dispute with Laxey, the Board's overriding goal remains to ensure Implenia's independence so that it can continue to apply its successful business model.

Contact:
Hirzel.Neef.Schmid. Konsulenten
Aloys Hirzel
Tel.: +41 43 344 42 42
E-mail: aloys.hirzel@konsulenten.ch